2019
DOI: 10.1016/j.oraloncology.2019.03.019
|View full text |Cite
|
Sign up to set email alerts
|

Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(28 citation statements)
references
References 34 publications
0
27
0
1
Order By: Relevance
“…13,[15][16][17][18][19][20] In addition, we noted the performance of the oral HPV 16 test was significantly lower among younger cases and those diagnosed with earlier disease that can be treated with monotherapy. 20 Hence, additional biomarkers are needed to improve oral HPV 16 test characteristics to identify OPC early.…”
Section: Introductionmentioning
confidence: 76%
See 2 more Smart Citations
“…13,[15][16][17][18][19][20] In addition, we noted the performance of the oral HPV 16 test was significantly lower among younger cases and those diagnosed with earlier disease that can be treated with monotherapy. 20 Hence, additional biomarkers are needed to improve oral HPV 16 test characteristics to identify OPC early.…”
Section: Introductionmentioning
confidence: 76%
“…However, agreement between oral rinses and tumor HPV 16 DNA has been variable, ranging between 59 and 96%, with most studies reporting values of approximately 70–80% . In addition, we noted the performance of the oral HPV 16 test was significantly lower among younger cases and those diagnosed with earlier disease that can be treated with monotherapy . Hence, additional biomarkers are needed to improve oral HPV 16 test characteristics to identify OPC early.…”
Section: Introductionmentioning
confidence: 81%
See 1 more Smart Citation
“…Several authors have shown a significant correlation between HPV DNA detected in tissue and positivity for HPV DNA in saliva, suggesting the potential value of this biofluid for detecting HPV and thus predicting HPV-related head and neck carcinomas [1,50]. Furthermore, salivary HPV DNA has demonstrated to be a good marker for detecting HPV in oropharyngeal cancer, as a high agreement between salivary HPV16 DNA infection and tumor p16 expression has been observed [51][52][53]. However, a recent study revealed a lower sensitivity for identifying p16-positive oral cancer patients through salivary HPV, which may indicate a limited involvement of HPV16 in oral carcinogenesis [54].…”
Section: Discussionmentioning
confidence: 96%
“…Cont. OC, oral cancer; OPC, oropharynx cancer; PCR, polymerase chain reaction; qPCR, quantitative PCR; FAP-PCR, fluorescent arbitrarily primed PCR; NGS, next-generation sequencing; * HR-HPV other:31,33,35,39,45,51,52, 56, 58, 59, 66, and 68; ** HPV α-9 other than HPV16: 31,33,35,52,58, and 67; *** HPV other:6, 11, 18, 26, 34, 39, 40, 42, 44, 45, 51, 53, 54, 56, 59, 61, 62, 66, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, and 89.…”
mentioning
confidence: 99%